OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
November 09, 2020
Interim analysis results from a phase 3 clinical trial reported a vaccine efficacy rate above 90% for BNT162b2. The trial is ongoing until it meets its threshold for confirmed COVID-19 cases.
November 03, 2020
The UK study examined the cross-sectional association between vitamins A, E, C, and D and respiratory complaints.
October 22, 2020
Remdesivir (Veklury; Gilead) is the first and only fully FDA-approved treatment for COVID-19.
October 21, 2020
The study results indicate that clinicians should take cognitive dysfunction into account in the management of COPD.
CBD and its impacts on a protective peptide show that the cannabinoid may reduce lung inflammation and damage.
October 20, 2020
Results of a phase 3 trial showed clinical benefits with dupilumab (Dupixent; Sanofi and Regeneron) in children with uncontrolled moderate-to-severe asthma.
The meta-analysis accrued data from 18 studies that focused on patients with hospitalized and chronic heart failure.
October 16, 2020
In an open letter, Pfizer Chairman and CEO wrote that safety and efficacy data for its COVID-19 vaccine candidate may be ready by the third week of November for FDA submission.
October 13, 2020
An investigation examines whether an intervention including both school and home components improves asthma outcomes.
October 12, 2020
Help patients with upper respiratory infections choose an OTC product that’s right for them.